<?xml version="1.0" encoding="UTF-8"?>
<p id="para0048">Preclinical studies in 
 <italic>Rhesus macaques</italic> immunized with three injections of purified inactivated SARS-CoV-2 (treated with b-propiolactone) induced an effective immune response, as evidenced by decreased viral load and protection against infection upon challenge of the monkey with SARS-CoV-2 
 <xref rid="bib0082" ref-type="bibr">[82]</xref>. Inactivated SARS-CoV-2 vaccines are currently being tested in early phase clinical trials.
</p>
